AstraZeneca's ‘Discrepancies’ in Vaccine Trial Accounts Spark Questions
Despite pressure to carry out further studies after two cases of serious illness, British-Swedish pharmaceutical company AstraZeneca has already resumed trials of its COVID-19 vaccine in Britain, Brazil, India, and South Africa, although the tests are still on hold in the US amid concerns from the National Institutes of Health.